The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles
Open accessAbstract
Near-infrared light-responsive inorganic nanoparticles have been shown to enhance the efficacy of cancer photothermal ablation therapy. However, current nanoparticle-mediated photothermal ablation is more effective in treating local cancer at the primary site than metastatic cancer. Here, we report the design of a near-infrared light-induced transformative nanoparticle platform that combines photothermal ablation with immunotherapy. The design is based on chitosan-coated hollow CuS nanoparticles that assemble the immunoadjuvants oligodeoxynucleotides containing the cytosine-guanine (CpG) motifs. Interestingly, these structures break down after laser excitation, reassemble, and transform into polymer complexes that improve tumor retention of the immunotherapy. In this "photothermal immunotherapy" approach, photothermal ablation-induced tumor cell death reduces tumor growth and releases tumor antigens into the surrounding milieu, while the immunoadjuvants potentiate host antitumor immunity. Our results indicated that combined photothermal immunotherapy is more effective than either immunotherapy or photothermal therapy alone against primary treated and distant untreated tumors in a mouse breast cancer model. These hollow CuS nanoparticles are biodegradable and can be eliminated from the body after laser excitation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
Kam, N. W. S., O'Connell, M., Wisdom, J. A., & Dai, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502680102 · Cited by 2,307
Tian, Q., Jiang, F., Zou, R., Liu, Q., Chen, Z., Zhu, M., Yang, S., Wang, J., Wang, J., & Hu, J. (2011) · ACS Nano · doi:10.1021/nn203293t · Cited by 1,282
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Dickerson, E. B., Dreaden, E. C., Huang, X., El-Sayed, I. H., Chu, H., Pushpanketh, S., McDonald, J. F., & El-Sayed, M. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.026 · Cited by 1,172
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Tian, Q., Tang, M., Sun, Y., Zou, R., Chen, Z., Zhu, M., Yang, S., Wang, J., Wang, J., & Hu, J. (2011) · Advanced Materials · doi:10.1002/adma.201101295 · Cited by 825
Zhou, M., Zhang, R., Huang, M., Lu, W., Song, S., Melancon, M. P., Tian, M., Liang, D., & Li, C. (2010) · Journal of the American Chemical Society · doi:10.1021/ja106855m · Cited by 718
Self-citationGold Nanocages as Photothermal Transducers for Cancer Treatment
Chen, J., Glaus, C., Laforest, R., Zhang, Q., Yang, M., Gidding, M., Welch, M. J., & Xia, Y. (2010) · Small · doi:10.1002/smll.200902216 · Cited by 691
Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells
Li, Y., Lu, W., Huang, Q., Li, C., & Chen, W. (2010) · Nanomedicine · doi:10.2217/nnm.10.85 · Cited by 634
Self-citationImmunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Vollmer, J., & Krieg, A. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.008 · Cited by 585
Gold Nanocages for Biomedical Applications
Skrabalak, S. E., Chen, J., Au, L., Lu, X., Li, X., & Xia, Y. (2007) · Advanced Materials · doi:10.1002/adma.200701972 · Cited by 506
Chen, C.-C., Lin, Y.-P., Wang, C.-W., Tzeng, H.-C., Wu, C.-H., Chen, Y.-C., Chen, C.-P., Chen, L.-C., & Wu, Y.-C. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0570180 · Cited by 424
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
Krieg, A. M. (2008) · Oncogene · doi:10.1038/sj.onc.1210911 · Cited by 388
Kortylewski, M., Swiderski, P., Herrmann, A., Wang, L., Kowolik, C., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1564 · Cited by 380
Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
Sasai, M., Linehan, M. M., & Iwasaki, A. (2010) · Science · doi:10.1126/science.1187029 · Cited by 357
Lu, W., Xiong, C., Zhang, G., Huang, Q., Zhang, R., Zhang, J. Z., & Li, C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1480 · Cited by 322
Self-citationGuo, L., Panderi, I., Yan, D. D., Szulak, K., Li, Y., Chen, Y.-T., Ma, H., Niesen, D. B., Seeram, N., Ahmed, A., et al. (2013) · ACS Nano · doi:10.1021/nn403202w · Cited by 316
Self-citationLiu, C., Lou, Y., Lizée, G., Qin, H., Liu, S., Rabinovich, B., Kim, G. J., Wang, Y.-H., Ye, Y., Sikora, A. G., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33583 · Cited by 316
Lu, W., Zhang, G., Zhang, R., Flores, L. G., Huang, Q., Gelovani, J. G., & Li, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3379 · Cited by 266
Self-citationWei, M., Chen, N., Li, J., Yin, M., Liang, L., He, Y., Song, H., Fan, C., & Huang, Q. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201105187 · Cited by 202
Hollow Copper Sulfide Nanoparticle‐Mediated Transdermal Drug Delivery
Ramadan, S. S., Guo, L., Li, Y., Yan, B., & Lü, W. (2012) · Small · doi:10.1002/smll.201200783 · Cited by 188
Self-citationCarbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
Zhao, D., Alizadeh, D., Zhang, L., Liu, W., Farrukh, O., Manuel, E., Diamond, D. J., & Badie, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2444 · Cited by 181
Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery
Lee, D., Zhang, W., Shirley, S. A., Kong, X., Hellermann, G. R., Lockey, R. F., & Mohapatra, S. S. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9136-9 · Cited by 178
Bourquin, C., Anz, D., Zwiorek, K., Lanz, A.-L., Fuchs, S. P., Weigel, S., Wurzenberger, C., von der Borch, P., Golić, M., Moder, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2990 · Cited by 174
Controlled release of plasmid DNA from gold nanorods induced by pulsed near-infrared light
Takahashi, H., Niidome, Y., & Yamada, S. (2005) · Chemical Communications · doi:10.1039/b500337g · Cited by 170
Lin, A. Y., Almeida, J. P. M., Bear, A. S., Liu, N., Luo, L., Foster, A. E., & Drezek, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063550 · Cited by 155
CpG Oligodeoxynucleotide Enhances Tumor Response to Radiation
Milas, L., Mason, K. A., Ariga, H., Hunter, N. R., Neal, R. E., Valdecanas, D. R., Krieg, A. Μ., & Whisnant, J. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0926 · Cited by 151
Overview of Tumor Cell–Based Vaccines
Copier, J. P., & Dalgleish, A. G. (2006) · International Reviews of Immunology · doi:10.1080/08830180600992472 · Cited by 126
Antitumor immunity induced by laser immunotherapy and its adoptive transfer.
Chen, W. R., Singhal, A. K., Liu, H., & Nordquist, R. E. (2001) · PubMed · Cited by 114
CpG Oligodeoxyneucleotides as TLR9 Agonists: Therapeutic Applications in Cancer
Murad, Y. M., & Clay, T. M. (2009) · BioDrugs · doi:10.2165/11316930-000000000-00000 · Cited by 110
Hodge, J. W., Guha, C., Neefjes, J., & Gulley, J. L. (2008) · PubMed · Cited by 108
Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
Wilson, K. D., de Jong, S. D., & Tam, Y. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.014 · Cited by 102
In situ photoimmunotherapy: a tumour-directed treatment for melanoma
Naylor, M. F., Chen, W. R., Teague, T. K., Perry, L., & Nordquist, R. E. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07514.x · Cited by 94
Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles
Malyala, P., O’Hagan, D. T., & Singh, M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.009 · Cited by 82
Xia, Y., Gupta, G. K., Castaño, A. P., Mróz, P., Avci, P., & Hamblin, M. R. (2013) · Journal of Biophotonics · doi:10.1002/jbio.201300072 · Cited by 59
Fan, H., Zhang, I., Chen, X., Zhang, L., Wang, H., Fonseca, A. D., Manuel, E. R., Diamond, D. J., Raubitschek, A. A., & Badie, B. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1911 · Cited by 58
de Jong, S. D., Basha, G., Wilson, K. D., Kazem, M., Cullis, P. R., Jefferies, W., & Tam, Y. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0802442 · Cited by 53
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors
Mason, K. A., Neal, R. E., Hunter, N. R., Ariga, H., Ang, K. K., & Milas, L. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.024 · Cited by 52
Kim, J. H., Noh, Y., Heo, M. B., Cho, M. Y., & Lim, Y. T. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204989 · Cited by 49
Kim, J. H., Noh, Y., Heo, M. B., Cho, M. Y., & Lim, Y. T. (2012) · Angewandte Chemie · doi:10.1002/ange.201204989 · Cited by 43
Bae, S., Kim, Y., Kwak, S., Kim, Y., Ro, D., Shin, J., Park, C., Han, S., Oh, C., Kim, C., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00447.x · Cited by 36
Ejrnaes, M., Videbæk, N., Christen, U., Cooke, A., Michelsen, B. K., & von Herrath, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2746 · Cited by 34
Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells
Schreiber, H. A., Prechl, J., Jiang, H., Zozulya, A. L., Fábry, Z., Denes, F. S., & Sándor, M. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.02.009 · Cited by 33
CpG plus radiotherapy: a review of preclinical works leading to clinical trial
Mason, K. A., & Hunter, N. R. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00101 · Cited by 30
Pouyanfard, S., Bamdad, T., Hashemi, H., Bandehpour, M., & Kazemi, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049539 · Cited by 26
Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles
Chikh, G., de Jong, S. D., Sekirov, L., Raney, S. G., Kazem, M., Wilson, K. D., Cullis, P. R., Dutz, J. P., & Tam, Y. K. (2009) · International Immunology · doi:10.1093/intimm/dxp044 · Cited by 24
Cited by
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Chen, Q., Xu, L., Liang, C., Wang, C., Peng, R., & Liu, Z. (2016) · Nature Communications · doi:10.1038/ncomms13193 · Cited by 1,596
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Compound Copper Chalcogenide Nanocrystals
Coughlan, C., Ibáñez, M., Dobrozhan, O., Singh, A., Cabot, A., & Ryan, K. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00376 · Cited by 930
Metadata
- Authors
- Guo, L., Yan, D. D., Yang, D., Li, Y., Wang, X., Zalewski, O., Yan, B., & Lu, W.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-05-13
- Volume
- 8
- Issue
- 6
- Pages
- 5670-5681
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W1965118563
- Cited by
- 532
- References
- 48
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.